Abiomed, Inc's Revenue and Profits Soar Yet Again
Abiomed (NASDAQ: ABMD), a medical-device maker focused on minimally invasive heart pumps, reported its fiscal second-quarter earnings on Thursday, Oct. 26. The company once again reported strong growth in sales of its Impella family of heart pumps and raised guidance.
Let's take a closer look at the company's results.
Image source: Getty Images.
Source: Fool.com
